Baillie Gifford - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$465
-39.6%
3080.0%0.00%
Q4 2022$770
-23.0%
3080.0%0.00%
Q3 2022$1,0000.0%3080.0%0.00%
Q2 2022$1,000
-50.0%
3080.0%0.00%
Q1 2022$2,000
-33.3%
3080.0%0.00%
Q4 2021$3,0000.0%3080.0%0.00%
Q3 2021$3,000
-40.0%
3080.0%0.00%
Q2 2021$5,0000.0%3080.0%0.00%
Q1 2021$5,000
-28.6%
308
-5.5%
0.00%
Q4 2020$7,0003260.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders